Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
Open | $5.540 |
Close | - |
Volume / Avg. | 8.226K / 30.571K |
Day Range | 5.540 - 5.900 |
52 Wk Range | 2.780 - 8.847 |
Market Cap | $32.038M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 2.39% |
Days to Cover | 11.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aprea Therapeutics (NASDAQ: APRE) through any online brokerage.
Other companies in Aprea Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Lumos Pharma (NASDAQ:LUMO) and Viracta Therapeutics (NASDAQ:VIRX).
The latest price target for Aprea Therapeutics (NASDAQ: APRE) was reported by HC Wainwright & Co. on Tuesday, May 14, 2024. The analyst firm set a price target for 20.00 expecting APRE to rise to within 12 months (a possible 238.98% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $5.9 last updated Today at May 14, 2024 at 3:30 PM EDT.
There are no upcoming dividends for Aprea Therapeutics.
Aprea Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Aprea Therapeutics.
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.